Aytu Biopharma Inc (AYTU) has risen 15.17% in a Week, Should You Buy?

A rating of 97 puts Aytu Biopharma Inc (AYTU) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Aytu Biopharma Inc's score of 97 means it scores higher than 97% of stocks in the industry. Aytu Biopharma Inc also received an overall rating of 72, putting it above 72% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 110 out of the 148 industries.

AYTU has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on AYTU!

See Full AYTU Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aytu Biopharma Inc Stock Today?

Aytu Biopharma Inc (AYTU) stock has risen 6.37% while the S&P 500 is lower by -1.02% as of 1:16 PM on Wednesday, Oct 18. AYTU is up $0.20 from the previous closing price of $3.14 on volume of 87,506 shares. Over the past year the S&P 500 is higher by 16.36% while AYTU is lower by -0.30%. AYTU lost -$5.11 per share the over the last 12 months. Click Here to get the full Stock Report for Aytu Biopharma Inc stock.